Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Insmed Inc(INSM) | 750,000 | 1,600,000 | +850,000 | 50,250 | 116,800 | 9.22% | +66,550 |
| Inari Medical Inc | 350,000 | 1,550,000 | +1,200,000 | 16,853 | 63,922 | 5.04% | +47,070 |
| Agios Pharmaceuticals Inc(AGIO) | 0 | 760,000 | +760,000 | 0 | 33,767 | 2.66% | +33,767 |
| Structure Therapeutics Inc | 560,000 | 1,150,000 | +590,000 | 21,991 | 50,474 | 3.98% | +28,482 |
| BioMarin Pharmaceutical Inc(BMRN) | 0 | 400,000 | +400,000 | 0 | 28,116 | 2.22% | +28,116 |
| Avadel Pharmaceuticals PLC(Put) | 0 | 2,000,000 | +2,000,000 | 0 | 26,230 | — | +26,230 |
| Biohaven Ltd(BHVN)(Call) | 0 | 500,000 | +500,000 | 0 | 24,985 | — | +24,985 |
| KalVista Pharmaceuticals Inc | 2,300,000 | 4,000,000 | +1,700,000 | 27,094 | 46,320 | 3.65% | +19,226 |
| Arcellx Inc COMMON STOCK | 675,000 | 675,000 | 0 | 37,253 | 56,369 | 4.45% | +19,116 |
| Edwards Lifesciences Corp | 0 | 275,000 | +275,000 | 0 | 18,147 | 1.43% | +18,147 |
| Day One Biopharmaceuticals Inc COM | 1,250,000 | 2,500,000 | +1,250,000 | 17,225 | 34,825 | 2.75% | +17,600 |
| Gilead Sciences Inc(GILD) | 0 | 200,000 | +200,000 | 0 | 16,768 | 1.32% | +16,768 |
| Agilent Technologies Inc(A) | 0 | 100,000 | +100,000 | 0 | 14,848 | 1.17% | +14,848 |
| Astria Therapeutics Inc | 3,250,000 | 4,000,000 | +750,000 | 29,575 | 44,040 | 3.47% | +14,465 |
| GSK PLC(GSK) | 0 | 300,000 | +300,000 | 0 | 12,264 | 0.97% | +12,264 |
| Black Diamond Therapeutics Inc | 2,100,000 | 5,028,500 | +2,928,500 | 9,786 | 21,874 | 1.73% | +12,088 |
| Xenon Pharmaceuticals Inc(XENE) | 525,000 | 825,000 | +300,000 | 20,470 | 32,480 | 2.56% | +12,011 |
| Immatics NV(IMTX) | 2,750,000 | 3,750,000 | +1,000,000 | 31,955 | 42,788 | 3.38% | +10,833 |
| Bicara Therapeutics Inc | 0 | 425,000 | +425,000 | 0 | 10,825 | 0.85% | +10,825 |
| Crinetics Pharmaceuticals Inc(CRNX) | 0 | 205,000 | +205,000 | 0 | 10,476 | 0.83% | +10,476 |
| Sanofi SA(SNY) | 0 | 150,000 | +150,000 | 0 | 8,645 | 0.68% | +8,645 |
| Bruker Corp(BRKR) | 0 | 125,000 | +125,000 | 0 | 8,633 | 0.68% | +8,633 |
| Savara Inc(SVRA) | 6,490,000 | 8,090,000 | +1,600,000 | 26,155 | 34,302 | 2.71% | +8,147 |
| Apogee Therapeutics Inc(APGE) | 0 | 136,500 | +136,500 | 0 | 8,018 | 0.63% | +8,018 |
| Tarsus Pharmaceuticals Inc(TARS) | 0 | 230,000 | +230,000 | 0 | 7,565 | 0.60% | +7,565 |
| Becton Dickinson & Co(BDX) | 0 | 30,000 | +30,000 | 0 | 7,233 | 0.57% | +7,233 |
| Madrigal Pharmaceuticals Inc(MDGL) | 0 | 30,000 | +30,000 | 0 | 6,367 | 0.50% | +6,367 |
| Legend Biotech Corp(LEGN) | 0 | 125,000 | +125,000 | 0 | 6,091 | 0.48% | +6,091 |
| UroGen Pharma Ltd(URGN) | 0 | 400,000 | +400,000 | 0 | 5,080 | 0.40% | +5,080 |
| Geron Corp(GERN) | 0 | 1,050,000 | +1,050,000 | 0 | 4,767 | 0.38% | +4,767 |
| Solid Biosciences Inc | 2,665,000 | 2,800,000 | +135,000 | 15,111 | 19,516 | 1.54% | +4,405 |
| Zymeworks Inc(ZYME) | 440,000 | 615,000 | +175,000 | 3,744 | 7,718 | 0.61% | +3,974 |
| Zevra Therapeutics Inc | 0 | 525,000 | +525,000 | 0 | 3,644 | 0.29% | +3,644 |
| Ardelyx Inc | 0 | 500,000 | +500,000 | 0 | 3,445 | 0.27% | +3,445 |
| Penumbra Inc(PEN) | 0 | 15,000 | +15,000 | 0 | 2,915 | 0.23% | +2,915 |
| Intra-Cellular Therapies Inc | 0 | 30,000 | +30,000 | 0 | 2,195 | 0.17% | +2,195 |
| uniQure NV(QURE) | 4,750,000 | 4,750,000 | 0 | 21,280 | 23,418 | 1.85% | +2,138 |
| Prime Medicine Inc | 450,000 | 1,070,000 | +620,000 | 2,313 | 4,141 | 0.33% | +1,828 |
| Establishment Labs Holdings In(ESTA) | 0 | 40,000 | +40,000 | 0 | 1,731 | 0.14% | +1,731 |
| Monte Rosa Therapeutics Inc(GLUE) | 890,000 | 930,000 | +40,000 | 3,329 | 4,929 | 0.39% | +1,600 |
| Alto Neuroscience Inc(ANRO) | 620,000 | 650,000 | +30,000 | 6,628 | 7,436 | 0.59% | +808 |
| Ventyx Biosciences Inc | 1,315,000 | 1,725,000 | +410,000 | 3,038 | 3,761 | 0.30% | +723 |
| Galapagos NV(LKFT) | 180,000 | 180,000 | 0 | 4,460 | 5,182 | 0.41% | +722 |
| Reneo Pharmaceuticals Inc | 545,000 | 799,400 | +254,400 | 823 | 1,359 | 0.11% | +536 |
| Achilles Therapeutics PLC | 1,500,000 | 1,500,000 | 0 | 1,223 | 1,530 | 0.12% | +308 |
| Tenax Therapeutics Inc | 0 | 83,333 | +83,333 | 0 | 288 | 0.02% | +288 |
| PTC Therapeutics Inc(PTCT) | 90,000 | 80,000 | -10,000 | 2,752 | 2,968 | 0.23% | +216 |
| Verve Therapeutics Inc | 500,000 | 525,000 | +25,000 | 2,440 | 2,541 | 0.20% | +101 |
| Chimerix Inc | 1,400,000 | 1,400,000 | 0 | 1,226 | 1,302 | 0.10% | +76 |
| Atara Biotherapeutics Inc | 112,000 | 124,677 | +12,677 | 952 | 1,014 | 0.08% | +62 |
| Newamsterdam Pharma Co NV ORDINARY SHARES | 25,000 | 0 | -25,000 | 480 | 0 | — | -480 |
| Passage Bio Inc | 6,052,000 | 6,100,000 | +48,000 | 4,806 | 4,270 | 0.34% | -536 |
| Fate Therapeutics Inc | 2,000,000 | 1,685,000 | -315,000 | 6,560 | 5,898 | 0.47% | -662 |
| MacroGenics Inc | 800,000 | 830,000 | +30,000 | 3,400 | 2,731 | 0.22% | -669 |
| Nurix Therapeutics Inc(NRIX) | 500,000 | 425,000 | -75,000 | 10,435 | 9,550 | 0.75% | -885 |
| Allogene Therapeutics Inc | 2,200,000 | 1,500,000 | -700,000 | 5,126 | 4,200 | 0.33% | -926 |
| Voyager Therapeutics Inc | 600,000 | 490,000 | -110,000 | 4,746 | 2,867 | 0.23% | -1,879 |
| Relmada Therapeutics Inc | 1,200,000 | 490,000 | -710,000 | 3,600 | 1,588 | 0.13% | -2,012 |
| Iovance Biotherapeutics Inc(IOVA) | 300,000 | 0 | -300,000 | 2,406 | 0 | — | -2,406 |
| Dianthus Therapeutics Inc(DNTH) | 600,000 | 395,000 | -205,000 | 15,528 | 10,815 | 0.85% | -4,713 |
| Lexeo Therapeutics Inc | 840,000 | 850,000 | +10,000 | 13,474 | 7,684 | 0.61% | -5,790 |
| Liquidia Corp(LQDA) | 1,830,000 | 1,500,000 | -330,000 | 21,960 | 15,000 | 1.18% | -6,960 |
| Fulcrum Therapeutics Inc | 1,160,000 | 0 | -1,160,000 | 7,192 | 0 | — | -7,192 |
| Bristol-Myers Squibb Co(BMY) | 500,000 | 250,000 | -250,000 | 20,765 | 12,935 | 1.02% | -7,830 |
| Dyne Therapeutics Inc(DYN) | 225,000 | 0 | -225,000 | 7,940 | 0 | — | -7,940 |
| Pacira BioSciences Inc(PCRX) | 280,000 | 0 | -280,000 | 8,011 | 0 | — | -8,011 |
| Inspire Medical Systems Inc(INSP) | 60,000 | 0 | -60,000 | 8,030 | 0 | — | -8,030 |
| BioNTech SE(BNTX) | 100,000 | 0 | -100,000 | 8,036 | 0 | — | -8,036 |
| Janux Therapeutics Inc(JANX) | 725,000 | 485,000 | -240,000 | 30,370 | 22,034 | 1.74% | -8,337 |
| Denali Therapeutics Inc(DNLI) | 500,000 | 0 | -500,000 | 11,610 | 0 | — | -11,610 |
| Immunome Inc(IMNM) | 1,000,000 | 0 | -1,000,000 | 12,100 | 0 | — | -12,100 |
| Soleno Therapeutics Inc | 1,200,000 | 720,000 | -480,000 | 48,960 | 36,353 | 2.87% | -12,607 |
| Apellis Pharmaceuticals Inc COM | 335,000 | 0 | -335,000 | 12,851 | 0 | — | -12,851 |
| iTeos Therapeutics Inc | 1,750,000 | 1,025,000 | -725,000 | 25,970 | 10,465 | 0.83% | -15,505 |
| Applied Therapeutics Inc | 5,430,000 | 1,145,000 | -4,285,000 | 25,358 | 9,733 | 0.77% | -15,626 |
| Praxis Precision Medicines Inc(PRAX) | 440,000 | 0 | -440,000 | 18,198 | 0 | — | -18,198 |
| ALX Oncology Holdings Inc | 3,600,000 | 0 | -3,600,000 | 21,708 | 0 | — | -21,708 |
| Axsome Therapeutics Inc(AXSM) | 300,000 | 0 | -300,000 | 24,150 | 0 | — | -24,150 |
| Ultragenyx Pharmaceutical Inc(RARE) | 1,800,000 | 750,000 | -1,050,000 | 73,980 | 41,663 | 3.29% | -32,317 |
| Cytokinetics Inc(CYTK) | 2,075,000 | 1,500,000 | -575,000 | 112,424 | 79,200 | 6.25% | -33,223 |
| Exact Sciences Corp(EXK) | 925,000 | 0 | -925,000 | 39,081 | 0 | — | -39,081 |
| BeiGene Ltd(ONC) | 350,000 | 0 | -350,000 | 49,935 | 0 | — | -49,934 |
| Jazz Pharmaceuticals PLC(JAZZ) | 1,500,000 | 900,000 | -600,000 | 160,095 | 100,269 | 7.91% | -59,826 |
| Globus Medical Inc(GMED) | 900,000 | 0 | -900,000 | 61,641 | 0 | — | -61,641 |
| Ascendis Pharma A/S(ASND) | 750,000 | 250,000 | -500,000 | 102,285 | 37,328 | 2.95% | -64,957 |